🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Anal Cancer 101 video! Treatment for anal cancer relatively straightforward for most, but several nuances (i.e. anal margin, etc) & trials coming down pipeline aiming to better tailor care to stage/biology. I review in this 17 min video. Full video link & slides below 🧵. 1/6

Check out this recent Annals of Oncology #ctDNA review and meta-analysis👉Circulating tumor DNA clearance as a predictive biomarker of pathologic complete response in patients with solid tumors treated with neoadjuvant immune checkpoint inhibitors. 👉pubmed.ncbi.nlm.nih.gov/40187491/

Long-Term Efficacy of Pembrolizumab and the Clinical Utility of ctDNA in Locally Advanced dMMR/MSI-H Solid Tumors Nature Communications doi.org/10.1038/s41467… 👉undetectable ctDNA after pembrolizumab were more likely to have pCR and higher 2-year EFS rate 🧐ctDNA helpful for decision

Congratulations to my friend and MD Anderson Cancer Center co-fellow Inimfon Jackson on her award, LBJ 2nd year fellow of the year! So well deserved! 🤩✨👏🏼

Happy to finally share our work showing biweekly dosing of TAS-102 reduces rates of myelosuppression while maintaining efficacy in pts with mCRC Fox Chase Cancer Center Vanderbilt University Medical Center University of Wisconsin Department of Medicine Dr. Cathy Eng Michael LaPelusa, MD academic.oup.com/oncolo/article…

What a way to start #ASCO25 with this stellar group! Congratulations to all awardees from the Conquer Cancer, the ASCO Foundation ASCO from MD Anderson Cancer Center! And special thank you to my mentor Hind Rafei and fearless leader Christopher Flowers for joining the ceremony :) #endcancer #conquercancer

Neeta Somaiah, MD Elise Nassif Haddad ASCO Ryan Huey, MD, MS Jiasen He Juan Fueyo Our Dr. Mir Lim, a fellow in Cancer Medicine, shared a new analysis of complement activation signatures in colorectal cancer, which will help guide future therapeutic strategies. Van Morris, MD Scott Kopetz John Paul Shen ASCO #ASCO25 #EndCancer

The NextGen Disruptor Award, given in partnership w/ Healio Community, goes to Nazli Dizman! Dr. Dizman is... 💚 a second-year fellow at MD Anderson Cancer Center 💚 a voice for international medical graduates 💚 contributing to renal cell carcinoma research Congratulations!

Congratulations to the MD Anderson Cancer Center trainees who received 2025 Conquer Cancer, the ASCO Foundation Young Investigator and Merit Awards for their contributions to cancer research! Extremely grateful for your hard work and commitment to our mission to #EndCancer. So well-deserved!

The new tumour board? ⁦Nature Cancer⁩ - multimodel AI agent integrates patient data using GPT-4, MSI/KRAS/BRAF slides, radiologic images, OncoKB/PubMed/Google - AI agent makes correct clinical decision in 91% cases ⁦Jakob Nikolas Kather⁩ ⁦OncoAlert⁩ nature.com/articles/s4301…